Company: LIMN
Filing Date: 2025-08-11
Form Type: CORRESP
Source: 0001104659-25-076067
Chunk: 0

Company: Liminatus Pharma, Inc.
Filing Date: 2025-08-11
Form: CORRESP
Chunk 0
---
<div align='center'>Liminatus Pharma, Inc.

6 Centerpointe Drive #625

La Palma, CA 90623</div>

VIA EDGAR

August 11, 2025

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Tyler Howes

Tim Buchmiller

| Re: | Liminatus Pharma, Inc.             |
|     | Registration Statement on Form S-1 |
|     | File No. 333-288289                |

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act
of 1933, as amended, Liminatus Pharma, Inc. hereby requests acceleration of effectiveness of the above referenced Registration Statement
so that it will become effective at 4:00 p.m., Eastern Time, on August 12, 2025, or as soon as thereafter practicable.

| Very truly yours,       |
| /s/ Chris Kim           |
| Chris Kim,              
 Chief Executive Officer |